$57.18
+0.27 (+0.47%)
Last updated: May 31, 2026 04:47
Fundamentals Overview
Bristol-Myers Squibb Company is in the middle of its 52-week range with attractive valuation, trading relatively flat today.
Valuation attractive
Intrinsic value (DCF)
+380.4% upside vs price
Profitability
Risk (Beta)
0.26 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +380.4% upside vs price · Analyst grade: B+ · Sentiment improving (3 upgrades)
Pressures (Sell):
3M vs S&P 500: -15.9%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 7, Equal Weight: 4, Hold: 1, Neutral: 11, Outperform: 1, Overweight: 2, Sector Perform: 2, Underweight: 2.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $274.69; current price is $57.18. That’s a +380.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 16.06 |
| DCF value (model) | $274.69 (380.4% upside) |
| PEG (TTM) | 0.47 |
| P/B (TTM) | 5.82 |
| P/S (TTM) | 2.41 |
| P/FCF (TTM) | 9.81 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.42 |
| Quick Ratio (TTM) | 1.28 |
| Cash Ratio (TTM) | 0.5 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 15.01% |
| Gross margin (TTM) | 68.75% |
| Operating margin (TTM) | 25.67% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for BMY.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| B of A Securities | maintain | Buy | Buy | 2026-04-09 |
| Guggenheim | maintain | Buy | Buy | 2026-04-08 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2026-04-08 |
| HSBC | maintain | Hold | Hold | 2026-03-17 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-02-23 |
| Guggenheim | maintain | Buy | Buy | 2026-02-06 |
| Citigroup | maintain | Neutral | Neutral | 2026-02-06 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2026-02-06 |
| Piper Sandler | maintain | Overweight | Overweight | 2026-01-28 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-27 |
| Leerink Partners | maintain | Outperform | Outperform | 2026-01-13 |
| Scotiabank | maintain | Sector Perform | Sector Perform | 2026-01-09 |
| UBS | upgrade | Neutral | Buy | 2026-01-07 |
| Citigroup | maintain | Neutral | Neutral | 2026-01-07 |
| B of A Securities | upgrade | Neutral | Buy | 2025-12-15 |
| Guggenheim | upgrade | Neutral | Buy | 2025-12-12 |
| Morgan Stanley | maintain | Underweight | Underweight | 2025-12-12 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-12-10 |
| Scotiabank | maintain | Sector Perform | Sector Perform | 2025-12-04 |
| Goldman Sachs | maintain | Neutral | Neutral | 2025-12-02 |
| Citigroup | maintain | Neutral | Neutral | 2025-11-17 |
| Citigroup | maintain | Neutral | Neutral | 2025-08-01 |
| Morgan Stanley | maintain | Underweight | Underweight | 2025-07-10 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-04-28 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2025-04-23 |
| Jefferies | maintain | Buy | Buy | 2025-04-23 |
| UBS | maintain | Neutral | Neutral | 2025-04-11 |
| Goldman Sachs | downgrade | Buy | Neutral | 2025-04-08 |
| Wells Fargo | maintain | Equal Weight | Equal Weight | 2025-02-07 |
| Cantor Fitzgerald | maintain | Neutral | Neutral | 2025-02-04 |